Regulatory role of CD39 and CD73 in tumor immunity

被引：6
|
作者：
Kaplinsky, Nicole [1 ]
Williams, Kada [1 ]
Watkins, Dean [1 ]
Adams, Molly [1 ]
Stanbery, Laura [2 ]
Nemunaitis, John [2 ]
机构：
[1] Univ Toledo, Coll Med, Toledo, OH 43614 USA
[2] Gradalis Inc, Dallas, TX 75006 USA
来源：
FUTURE ONCOLOGY | 2024年 / 20卷 / 19期
关键词：
adenosine pathway; antigen; CD39; CD73; ENTPD1; immunotherapy; tumor microenvironment; T-CELLS; EXTRACELLULAR ADENOSINE; ATP; DISEASE; GROWTH; CANCER; INHIBITION; THERAPY;
D O I：
10.2217/fon-2023-0871
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CD39 is the rate-limiting enzyme for the molecular signal cascade leading to the generation of ADP and adenosine monophosphate (AMP). In conjunction with CD73, CD39 converts adenosine triphosphate (ATP) to ADP and AMP, which leads to the accumulation of immunosuppressive adenosine in the tumor microenvironment. This review focuses on the role of CD39 and CD73 in immune response and malignant progression, including the expression of CD39 within the tumor microenvironment and its relationship to immune effector cells, and its role in antigen presentation. The role of CD39- and CD73-targeting therapeutics and cancer-directed clinical trials investigating CD39 modulation are also explored.
引用
收藏
页码：1367 / 1380
页数：14
相关论文
共 50 条
  • [41] Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression
    Munoz-Godinez, Ricardo
    de Lourdes Mora-Garcia, Maria
    Weiss-Steider, Benny
    Montesinos-Montesinos, Juan Jose
    del Carmen Aguilar-Lemarroy, Adriana
    Garcia-Rocha, Rosario
    Hernandez-Montes, Jorge
    Azucena Don-Lopez, Christian
    Avila-Ibarra, Luis Roberto
    Torres-Pineda, Daniela Berenice
    Molina-Castillo, Gabriela
    Chacon-Salinas, Rommel
    Vallejo-Castillo, Luis
    Perez-Tapia, Sonia Mayra
    Monroy-Garcia, Alberto
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [42] Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73
    Turner, Ross J.
    Geraghty, Nicholas J.
    Williams, Jonathan G.
    Ly, Diane
    Brungs, Daniel
    Carolan, Martin G.
    Guy, Thomas, V
    Watson, Debbie
    de Leon, Jeremiah F.
    Sluyter, Ronald
    PURINERGIC SIGNALLING, 2020, 16 (03) : 389 - 401
  • [43] Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium
    Kaniewska-Bednarczuk, Ewa
    Mielcarek, Michal
    Chester, Adrian H.
    Slominska, Ewa M.
    Yacoub, Magdi H.
    Smolenski, Ryszard T.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2016, 35 (10-12) : 713 - 719
  • [44] Exploring the expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study
    Lima, Cibelle Freitas
    Tamegnon, Auriole
    Rodriguez, Saxon
    Maru, Dipen
    Martin, Philip L.
    Cooper, Zachary A.
    Rodriguez-Canales, Jaime
    Parra, Edwin Roger
    PATHOBIOLOGY, 2024, 91 (03) : 205 - 218
  • [45] The CD73 immune checkpoint promotes tumor cell metabolic fitness
    Allard, David
    Cousineau, Isabelle
    Ma, Eric H.
    Allard, Bertrand
    Bareche, Yacine
    Fleury, Hubert
    Stagg, John
    ELIFE, 2023, 12
  • [46] Caffeine reduces viability, induces apoptosis, inhibits migration and modulates the CD39/CD73 axis in metastatic cutaneous melanoma cells
    Manica, Daiane
    da Silva, Gilnei Bruno
    de Lima, Jussara
    Cassol, Joana
    Dallagnol, Paula
    Narzetti, Rafael Antonio
    Moreno, Marcelo
    Bagatini, Margarete Dulce
    PURINERGIC SIGNALLING, 2024, 20 (04) : 385 - 397
  • [47] The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
    Bauer, Arthur
    Gebauer, Niklas
    Knief, Juliana
    Tharun, Lars
    Arnold, Nele
    Riecke, Armin
    Steinestel, Konrad
    Witte, Hanno M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3193 - 3208
  • [48] Expression and activity of extracellular ectoenzymes (CD39 and CD73) in aortic valves cells and in endothelial cells under the shear stress conditions
    Kaniewska, E. D.
    Sielicka, A.
    Sarathchandra, P.
    Pelikant-Malecka, I.
    Chester, A. H.
    Yacoub, M. H.
    Smolenski, R. T.
    FEBS JOURNAL, 2014, 281 : 561 - 562
  • [49] Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT
    Krueger, Julius
    Wellbrock, Jasmin
    Witt, Marius
    Kruppa, Niklas
    Muschhammer, Jana
    Bokemeyer, Carsten
    Modemann, Franziska
    Fiedler, Walter
    Behrmann, Lena
    Brauneck, Franziska
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [50] The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition
    Arthur Bauer
    Niklas Gebauer
    Juliana Knief
    Lars Tharun
    Nele Arnold
    Armin Riecke
    Konrad Steinestel
    Hanno M. Witte
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3193 - 3208
12345